keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Arg-Gly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, MMP-9, and iNOS. 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 Arg-Gly-Asp-Ser acetate 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 188 | 5日内发货 | ||
5 mg | ¥ 286 | 5日内发货 |
Arg-Gly-Asp-Ser 的其他形式现货产品:
产品描述 | Arg-Gly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, MMP-9, and iNOS. |
体外活性 | The Arg-Gly-Asp-Ser-modified surface causes up-regulation of αvβ3 integrin. Attachment to the Arg-Gly-Asp-Ser-treated membrane completely abolishes apoptosis induced by staurosporine, the Ca2+·Pi ion pair, and sodium nitroprusside. Arg-Gly-Asp-Ser-dependent resistance to apoptosis is eliminated, when the activity of the phosphatidylinositol 3-kinase pathway is inhibited [1]. Arg-Gly-Asp-Ser interacts with survivin, as well as with procaspase-3, -8 and -9. Arg-Gly-Asp-Ser-peptide binding to survivin is found to be specific, at high affinity (Kd: 27.5 μM) and locates at the survivin C-terminus [4]. |
体内活性 | Arg-Gly-Asp-Ser (2.5 or 5 mg/kg, 1 h before LPS) significantly inhibits LPS-induced MMP-9 activity in BAL fluid 4 h post-LPS. Arg-Gly-Asp-Ser (1, 2.5, or 5 mg/kg, i.p.) administers 1 h before LPS inhibited LPS-induced increases in TNF-α and MIP-2 levels in BAL fluid at 4 h post-LPS [2]. Arg-Gly-Asp-Ser peptide significantly reduces TNF-α and macrophage inflammatory protein (MIP)-2 production and decreases myeloperoxidase (MPO) and NF-κB activity [3]. |
别名 | Fibronectin tetrapeptide, RGDS peptide |
分子量 | 433.42 |
分子式 | C15H27N7O8 |
CAS No. | 91037-65-9 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (126.90 mM)
H2O: 25 mg/mL (57.68 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 2.3072 mL | 11.5362 mL | 23.0723 mL | 57.6808 mL |
5 mM | 0.4614 mL | 2.3072 mL | 4.6145 mL | 11.5362 mL | |
10 mM | 0.2307 mL | 1.1536 mL | 2.3072 mL | 5.7681 mL | |
20 mM | 0.1154 mL | 0.5768 mL | 1.1536 mL | 2.884 mL | |
50 mM | 0.0461 mL | 0.2307 mL | 0.4614 mL | 1.1536 mL | |
DMSO | 100 mM | 0.0231 mL | 0.1154 mL | 0.2307 mL | 0.5768 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Arg-Gly-Asp-Ser 91037-65-9 Others ArgGlyAspSer Fibronectin tetrapeptide RGDS peptide Arg Gly Asp Ser Inhibitor inhibitor inhibit